SCHEMBL11564159

SCHEMBL11564159

COC(=O)C(=O)c1c(N)oc2ccccc2c1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 4/20 0.49
▸ CA2 P00918 4/20 0.49
▸ KDM4E B2RXH2 6/20 0.48
▸ CYP2C9 P11712 4/20 0.47
▸ THRB P10828 1/20 0.47
▸ ALDH1A1 P00352 2/20 0.43
▸ CYP3A4 P08684 2/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ MAOA P21397 2/20 0.43
▸ GLA P06280 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ PGAM1 P18669 1/20 0.43
▸ CASP1 P29466 1/20 0.43
▸ CASP7 P55210 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ CA12 O43570 1/20 0.43
▸ CA9 Q16790 1/20 0.43
▸ NPC1 O15118 2/20 0.42
▸ MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11568180 0.81 MAPK1 (0.57) CA1CA2KDM4ECYP2C9ALDH1A1
SCHEMBL8752341 0.80 CA12 (0.55) CA1CA2KDM4ECYP2C9THRB
SCHEMBL11777344 0.79 CA1 (0.54) CA1CA2KDM4ECYP2C9THRB
SCHEMBL18018242 0.77 KDM4E (0.62) CA1CA2KDM4EALDH1A1HSD17B10
SCHEMBL28774097 0.77 CA1 (0.49) CA1CA2KDM4ECYP2C9THRB
SCHEMBL7355901 0.75 KDM4E (0.50) CA1CA2KDM4ECYP2C9THRB
SCHEMBL1772596 0.72 CYP2C9 (0.64) KDM4ECYP2C9ALDH1A1CYP3A4HSD17B10
SCHEMBL8802227 0.70 KDM4E (0.59) CA1CA2KDM4ECYP2C9THRB
Xanthone SCHEMBL5341136 0.69 MAOA (0.82) KDM4EALDH1A1CYP3A4HSD17B10MAOA
SCHEMBL19679786 0.67 NPC1 (0.63) CA1CA2KDM4ETHRBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0000488-A1 3-Oxaloamino-4-oxo-4H-1-benzopyrane compounds, process for their preparation and their pharmaceutical use CIBA-GEIGY AG (CH) 1979-02-07 — — EP disclosed
Send feedback